ENTERO Q1 FY27 results at a glance
ENTERO HEALTHCARE SOLU L Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹1,940 cr |
|---|
| Revenue YoY | +38.2% |
|---|
| Operating profit | ₹84.68 cr |
|---|
| Operating margin | 4.4% |
|---|
| Net profit | ₹38.16 cr |
|---|
| Net profit YoY | +37.3% |
|---|
| Net profit QoQ | +36.2% |
|---|
| Net margin | 2.0% |
|---|
| Basic EPS | ₹8.77 |
|---|
| TTM revenue | ₹7,128 cr |
|---|
| TTM net profit | ₹125 cr |
|---|
| TTM net margin | 1.8% |
|---|
ENTERO Q1 FY27 results: what the numbers say
ENTERO HEALTHCARE SOLU L (ENTERO) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹1,940 cr and a net profit of ₹38.16 cr, translating into earnings per share of ₹8.77.
Compared with the same quarter a year earlier, revenue grew strongly by +38.2% and net profit grew strongly by +37.3%. Profit trailing revenue growth suggests costs, interest or tax absorbed part of the topline gain.
Operating profit for the quarter stood at ₹84.68 cr, an operating margin of 4.4% versus 2.9% a year ago — a gain of 1.4 percentage points.
ENTERO quarter-wise results table
Revenue
₹1,940 cr
+38.2% YoY
Net profit
₹38.16 cr
+37.3% YoY
Operating profit
₹84.68 cr
+105.5% YoY
ENTERO HEALTHCARE SOLU L (ENTERO) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹1,940 cr | ₹84.68 cr | ₹38.16 cr | 4.4% | 2.0% | ₹8.77 | +37.3% | +36.2% |
| Q4 FY262026-03-31 | ₹1,910 cr | ₹71.25 cr | ₹28.01 cr | 3.7% | 1.5% | ₹6.44 | — | +1.4% |
| Q3 FY262025-12-31 | ₹1,707 cr | ₹57.98 cr | ₹27.63 cr | 3.4% | 1.6% | ₹6.35 | — | -12.6% |
| Q2 FY262025-09-30 | ₹1,571 cr | ₹52.23 cr | ₹31.6 cr | 3.3% | 2.0% | ₹7.26 | — | +13.7% |
| Q1 FY262025-06-30 | ₹1,404 cr | ₹41.2 cr | ₹27.8 cr | 2.9% | 2.0% | ₹6.39 | — | — |
| TTM (last 4 quarters) | ₹7,128 cr | ₹266 cr | ₹125 cr | 3.7% | 1.8% | ₹28.82 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
ENTERO quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
ENTERO HEALTHCARE SOLU L quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹1,940 cr | ₹1,910 cr | ₹1,707 cr | ₹1,571 cr | ₹1,404 cr |
|---|
| Total expenses | ₹1,856 cr | ₹1,839 cr | ₹1,649 cr | ₹1,519 cr | ₹1,363 cr |
|---|
| Gross profit | ₹221 cr | ₹207 cr | ₹173 cr | ₹161 cr | ₹140 cr |
|---|
| Operating profit (EBIT) | ₹84.68 cr | ₹71.25 cr | ₹57.98 cr | ₹52.23 cr | ₹41.2 cr |
|---|
| Operating margin | 4.4% | 3.7% | 3.4% | 3.3% | 2.9% |
|---|
| Interest cost | ₹20.57 cr | ₹17.31 cr | ₹14.01 cr | ₹12.4 cr | ₹10.66 cr |
|---|
| Profit before tax | ₹67.12 cr | ₹57.95 cr | ₹40.4 cr | ₹44.63 cr | ₹36.36 cr |
|---|
| Tax expense | ₹15.07 cr | ₹12.82 cr | ₹6.52 cr | ₹8.03 cr | ₹6.13 cr |
|---|
| Effective tax rate | 22.5% | 22.1% | 16.1% | 18.0% | 16.9% |
|---|
| Net profit (PAT) | ₹38.16 cr | ₹28.01 cr | ₹27.63 cr | ₹31.6 cr | ₹27.8 cr |
|---|
| Net profit margin | 2.0% | 1.5% | 1.6% | 2.0% | 2.0% |
|---|
| Basic EPS | ₹8.77 | ₹6.44 | ₹6.35 | ₹7.26 | ₹6.39 |
|---|
| Diluted EPS | ₹8.76 | ₹6.43 | ₹6.34 | ₹7.25 | ₹6.38 |
|---|
ENTERO results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +38.2% | — | — | — | — |
|---|
| Revenue QoQ | +1.6% | +11.9% | +8.6% | +11.9% | — |
|---|
| Operating profit YoY | +105.5% | — | — | — | — |
|---|
| Operating profit QoQ | +18.9% | +22.9% | +11.0% | +26.8% | — |
|---|
| Net profit YoY | +37.3% | — | — | — | — |
|---|
| Net profit QoQ | +36.2% | +1.4% | -12.6% | +13.7% | — |
|---|
| EPS YoY | +37.2% | — | — | — | — |
|---|
| EPS QoQ | +36.2% | +1.4% | -12.5% | +13.6% | — |
|---|
ENTERO annual results history
Full-year performance for ENTERO HEALTHCARE SOLU L, useful for reading each quarter in context.
ENTERO HEALTHCARE SOLU L annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹6,540 cr | ₹5,065 cr | ₹3,888 cr | ₹3,293 cr |
|---|
| Total expenses | ₹6,317 cr | ₹4,923 cr | ₹3,801 cr | ₹3,253 cr |
|---|
| Gross profit | ₹629 cr | ₹456 cr | ₹318 cr | ₹261 cr |
|---|
| Operating profit (EBIT) | ₹223 cr | ₹142 cr | ₹86.83 cr | ₹39.77 cr |
|---|
| Operating margin | 3.4% | 2.8% | 2.2% | 1.2% |
|---|
| Interest cost | ₹49.04 cr | ₹37.54 cr | ₹60.48 cr | ₹44.4 cr |
|---|
| Profit before tax | ₹179 cr | ₹139 cr | ₹35.56 cr | -₹3.69 cr |
|---|
| Tax expense | ₹33.5 cr | ₹31.31 cr | -₹4.24 cr | ₹7.42 cr |
|---|
| Effective tax rate | 18.7% | 22.6% | -11.9% | -201.1% |
|---|
| Net profit (PAT) | ₹115 cr | ₹94.82 cr | ₹39.11 cr | -₹11.56 cr |
|---|
| Net profit margin | 1.8% | 1.9% | 1.0% | -0.4% |
|---|
| Basic EPS | ₹26.44 | ₹21.80 | ₹10.81 | ₹-2.66 |
|---|
| Diluted EPS | ₹26.40 | ₹21.76 | ₹10.81 | ₹-2.66 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹1,940 cr against ₹1,404 cr in Q1 FY26, and ₹1,910 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +1.6%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹1,856 cr, or 95.6% of revenue, with operating profit grew +105.5% year on year.
Margins, tax and profitability
Net profit of ₹38.16 cr works out to a net margin of 2.0% compared with 2.0% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.
Below the operating line, ENTERO HEALTHCARE SOLU L reported profit before tax of ₹67.12 cr, a tax charge of ₹15.07 cr (effective rate 22.5%), interest cost of ₹20.57 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹28.01 cr in Q4 FY26 to ₹38.16 cr in Q1 FY27, a change of +36.2%.
Trailing twelve months and annual context
Across the trailing four quarters ENTERO HEALTHCARE SOLU L has generated revenue of ₹7,128 cr and net profit of ₹125 cr, a trailing net margin of 1.8%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹6,540 cr with net profit of ₹115 cr and EPS of ₹26.44, versus the prior year where revenue grew +29.1% and profit grew +21.3%.
What to watch in the next ENTERO quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
ENTERO HEALTHCARE SOLU L has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
ENTERO results coverage
No results report published for ENTERO yet — our desk covers each quarter within minutes of the filing.
ENTERO quarterly results FAQs
What were ENTERO HEALTHCARE SOLU L (ENTERO) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), ENTERO HEALTHCARE SOLU L reported revenue of ₹1,940 cr and net profit of ₹38.16 cr, a change of +37.3% year on year on +38.2% revenue growth. EPS stood at ₹8.77.
What is ENTERO profit margin in Q1 FY27?
ENTERO HEALTHCARE SOLU L posted a net profit margin of 2.0% and an operating margin of 4.4% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹7,128 cr and net profit ₹125 cr.
Did ENTERO results beat the previous quarter?
ENTERO HEALTHCARE SOLU L net profit changed +36.2% quarter on quarter, from ₹28.01 cr in Q4 FY26 to ₹38.16 cr in Q1 FY27.
When are ENTERO HEALTHCARE SOLU L (ENTERO) quarterly results?
ENTERO HEALTHCARE SOLU L has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see ENTERO latest quarterly results?
Results coverage for ENTERO will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the ENTERO stock page.
What is ENTERO HEALTHCARE SOLU L annual revenue and profit?
For FY26, ENTERO HEALTHCARE SOLU L reported full-year revenue of ₹6,540 cr and net profit of ₹115 cr, with EPS of ₹26.44.
How many quarterly results has ENTERO declared recently?
Past results dates for ENTERO will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 11 Sept 2026. For information only, not investment advice.
